Trial intelligence / Profile preview

Pentoxifylline for endothelial function in obesity

ISRCTN14884558Phase 4Completed

Sponsor
University of Leeds
Start
Dec 2010
Modality
Small Molecules
01

Overview

Phase 4, randomised trial of pentoxifylline in obesity and endothelial dysfunction, sponsored by University of Leeds. Primary endpoint: Flow mediated dilatation of brachial artery. Started Dec 2010; status: completed.

02

Drugs

pentoxifylline
03

Conditions

obesityendothelial dysfunction

Beyond the preview

Go deeper on ISRCTN14884558.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN14884558.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call